Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Whitehawk Therapeutics Inc. is a biopharmaceutical enterprise currently undergoing clinical trials.

52W Range

77thpctl

Volume

0.22×avg

Market Cap

263.38MUSD

P/E Ratio

-4.1TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Whitehawk Therapeutics Inc

WHWKNASDAQ Global Market·USD·Closed

Whitehawk Therapeutics Inc

WHWKNASDAQ·USD·Closed

$4.62

−5.13%

$4.62

−$0.25 (5.13%)

52W Range

77thpctl

Volume

0.22×avg

Mkt Cap

263.38MUSD

P/E

-4.1TTM

Div Yield

–ann

WHWK: Whitehawk Therapeutics Inc Stock Analysis | finqOS